Cronos Group


 

Income Statement Sep 30, 2016 Jun 30, 2016 Mar 31, 2016 Dec 31, 2015
Total Revenue 0.13 0 0 0
Gross Profit -0.13
Operating Income -0.45 -0.59 -0.47 -2.32
Net Income -0.23 -1.84 -0.49 2.02

Balance Sheet Sep 30, 2016 Jun 30, 2016 Mar 31, 2016 Dec 31, 2015
Total Assets 39.61 15.7 13.87 14.72
Total Liabilities 9.04 0.41 2.66 3.02
Total Equity 30.57 15.29 11.21 11.7

Cash Flow Sep 30, 2016 Jun 30, 2016 Mar 31, 2016 Dec 31, 2015
Period Length: 9 Months 6 Months 3 Months 12 Months
Cash From Operating Activities -4.72 -1.85 -0.75 -1.38
Cash From Investing Activities -7.09 -0.07 -0.06 -1.46
Cash From Financing Activities 16.46 4.26 0 3.17
Net Change in Cash 4.65 2.35 -0.81 0.33

* In Millions of CAD (except for per share items)


Price Target 2017 : $3.50       Analyst Consensus : STRONG BUY         Market Sentiment : Bullish


 

About Cronos Group (MJN:TSXV)

 

Cronos Group is a licensed producer with two operating facilities (Peace Naturals Project in Ontario, The Zone Produce in B.C.) licensed to produce a combined 2,600 kg. The Company also holds a portfolio of minority interests in other LPs (including Whistler Medical Marijuana, Hydropothecary, and Abcann Medicinals) and two ACMPR-applicants. MNN was also the vendor of Vert Medical to Canopy Growth Corporation. Cronos acquired the 75% it did not own in Peace Naturals in September 2016 for $8.8M in cash and holdbacks payable. Peace Naturals is licensed for production and sale, while The Zone Produce had its Health Canada inspection in late September 2016, and is awaiting the results of its application for a sales license. MNN recently announced a three-year agreement under which Peace Naturals will be the exclusive North American supplier to Pedanios GmbH, a German-based pharmaceutical wholesaler. The Company’s first exports were made in October 2016.


Investor Presentation ( Must Read) :

 

 

 http://thecronosgroup.com/wp-content/uploads/2017/02/CronosGroup-Investor-Deck-Jan-17.pdf


 

 

 

Source : Echelon wealth partners report